Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.7200
-0.0122 (-1.67%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Spero Therapeutics Employees
Spero Therapeutics had 32 employees as of December 31, 2024. The number of employees decreased by 14 or -30.43% compared to the previous year.
Employees
32
Change (1Y)
-14
Growth (1Y)
-30.43%
Revenue / Employee
$1,499,281
Profits / Employee
-$2,142,688
Market Cap
40.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
SPRO News
- 27 days ago - Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update - GlobeNewsWire
- 5 weeks ago - Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025 - GlobeNewsWire
- 2 months ago - UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Spero Therapeutics: Undervalued Based On Just Tebipenem And GSK Deal - Seeking Alpha
- 3 months ago - Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes - GlobeNewsWire
- 5 months ago - Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update - GlobeNewsWire